Christoph Bruening
Corporate Officer/Principal en Value Relations GmbH .
Perfil
Christoph Bruening has been a Director of Callisto Pharmaceuticals, Inc. since May 2003.
He is a Managing Partner of Value Relations GmbH and a Member of the Advisory board of Clarity AG.
Mr. Bruening was Funds Manager and Director-Asset Management of Value Management and Research AG from 1998 to 1999.
He was a Financial Analyst and Head-Research of Value Research GmbH from 1997 to 1998.
Cargos activos de Christoph Bruening
Empresas | Cargo | Inicio |
---|---|---|
Value Relations GmbH | Corporate Officer/Principal | 01/01/1999 |
Antiguos cargos conocidos de Christoph Bruening.
Empresas | Cargo | Fin |
---|---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Director/Miembro de la Junta | 26/05/2010 |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Callisto Pharmaceuticals, Inc. is a development stage biopharmaceutical company. The company operates through two subsidiary companies: Pharmaceuticals, Inc and Callisto Research Labs, LLC. It focuses primarily on the development of drugs to treat gastrointestinal disorder and diseases and rheumatoid arthritis and develops novel therapeutics to treat cancer. The company was founded by Judson A. Cooper and Joshua D. Schein in 1996 and is headquartered in New York, NY. | Health Technology |
Value Relations GmbH |
- Bolsa de valores
- Insiders
- Christoph Bruening